Sumeet Industries Clarifies Audit Qualification Impact for FY26
Sumeet Industries Limited provided a revised Statement of Impact of Audit Qualifications for FY26. The company reported a net profit of ₹2582.39 Lakhs and EPS of ₹0.48 for both standalone and consolidated results. A recurring audit qualification pertains to the non-provision of MSMED Act interest.
The announcement is a response to a regulatory query about the format of a previously submitted document. The financial figures disclosed are for the past financial year and do not indicate any significant new information or changes in the company's performance or outlook. The audit qualification, while noted, has been addressed with management's explanation.
The announcement is a clarification regarding an audit qualification and its format. While it provides financial figures for FY26, it does not contain new positive or negative business developments. The focus is on compliance and disclosure.
Sumeet Industries Limited has responded to a query from the National Stock Exchange of India Limited regarding the format of its Statement of Impact of Audit Qualifications for the financial year ended March 31, 2026. The company clarified that the statement, duly signed by the Managing Director, CFO, and Executive Director, was recommended by the Audit Committee in its meeting held on May 29, 2026. The company has enclosed a digitally signed copy of the statement, which details the impact of audit qualifications on both standalone and consolidated financial statements.
The primary audit qualification highlighted is the non-ascertainment and non-provision of interest payable as per Section 16 of the MSMED Act, 2006. This qualification has been noted as a "Qualified Opinion" and is a recurring issue, marked as "Second Time". The management stated that there is no quantified impact by the auditor, and they are unable to estimate the impact due to consistent business practices and mutual understanding with MSME vendors, where no interest has been demanded or charged. The auditors' comments confirm the management's submission regarding the non-provision of interest under the MSMED Act, 2006.
For the financial year ended March 31, 2026, the audited figures for both standalone and consolidated statements show a Turnover/Total Income of ₹105753.17 Lakhs, Total Expenditure of ₹102221.62 Lakhs, and a Total Comprehensive Net Profit/(Loss) of ₹2582.39 Lakhs. The Earnings Per Share stood at ₹0.48, Total Assets at ₹55081.27 Lakhs, Total Liabilities at ₹55081.27 Lakhs, and Net Worth at ₹21188.79 Lakhs. These figures remained unchanged after adjusting for the audit qualification.
What to do with a filing like this
Sumeet Industries Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sumeet Industries Limited. Read the original for the full detail.